Literature DB >> 27780483

A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older Australians.

Y Chen1, K Glass1, B Liu2, T V Riley3, R Korda1, M D Kirk1.   

Abstract

Clostridium difficile is the principal cause of infectious diarrhoea in hospitalized patients. We investigated the incidence and risk factors for hospitalization due to C. difficile infection (CDI) in older Australians. We linked data from a population-based prospective cohort study (the 45 and Up Study) of 266 922 adults aged ⩾45 years recruited in New South Wales, Australia to hospitalization and death records for 2006-2012. We estimated the incidence of CDI hospitalization and calculated days in hospital and costs per hospitalization. We also estimated hazard ratios (HR) for CDI hospitalization using Cox regression with age as the underlying time variable. Over a total follow-up of 1 126 708 person-years, 187 adults had an incident CDI hospitalization. The crude incidence of CDI hospitalization was 16·6/100 000 person-years, with a median hospital stay of 6 days, and a median cost of AUD 6102 per admission. Incidence increased with age and year of follow-up, with a threefold increase for 2009-2012. After adjustment, CDI hospitalization rates were significantly lower in males than females (adjusted HR 0·6, 95% confidence interval 0·4-0·7). CDI hospitalization rates increased significantly over 2009-2012. There is a need to better understand the increasing risk of CDI hospitalization in women.

Entities:  

Keywords:  zzm321990 Clostridium difficilezzm321990 ; epidemiology

Mesh:

Year:  2016        PMID: 27780483      PMCID: PMC9507632          DOI: 10.1017/S0950268816002260

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  32 in total

1.  Osteopathic physicians in the United States: antibiotic prescribing practices for patients with nonspecific upper respiratory tract infections.

Authors:  Chao Sun; Sherman Jew; Susan L Dasta
Journal:  J Am Osteopath Assoc       Date:  2006-08

Review 2.  Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen.

Authors:  Victor O Badger; Nate A Ledeboer; Mary Beth Graham; Charles E Edmiston
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-05-10       Impact factor: 4.016

3.  Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs.

Authors:  Nicole M Mealing; Emily Banks; Louisa R Jorm; David G Steel; Mark S Clements; Kris D Rogers
Journal:  BMC Med Res Methodol       Date:  2010-04-01       Impact factor: 4.615

4.  The epidemiology of community-acquired Clostridium difficile infection: a population-based study.

Authors:  Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

5.  Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.

Authors:  Lorraine Kyne; Stavros Sougioultzis; Lynne V McFarland; Ciarán P Kelly
Journal:  Infect Control Hosp Epidemiol       Date:  2002-11       Impact factor: 3.254

6.  Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Authors:  Amit S Chitnis; Stacy M Holzbauer; Ruth M Belflower; Lisa G Winston; Wendy M Bamberg; Carol Lyons; Monica M Farley; Ghinwa K Dumyati; Lucy E Wilson; Zintars G Beldavs; John R Dunn; L Hannah Gould; Duncan R MacCannell; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

7.  Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012.

Authors:  D W Eyre; L Tracey; B Elliott; C Slimings; P G Huntington; R L Stuart; T M Korman; G Kotsiou; R McCann; D Griffiths; W N Fawley; P Armstrong; K E Dingle; A S Walker; T E Peto; D W Crook; M H Wilcox; T V Riley
Journal:  Euro Surveill       Date:  2015-03-12

8.  Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional study.

Authors:  N F Foster; D A Collins; S L Ditchburn; C N Duncan; J W van Schalkwyk; C L Golledge; A B R Keed; T V Riley
Journal:  New Microbes New Infect       Date:  2014-04-01

9.  Clostridium difficile in retail meat products, USA, 2007.

Authors:  J Glenn Songer; Hien T Trinh; George E Killgore; Angela D Thompson; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

10.  Characteristics of patients with Clostridium difficile infection in Taiwan.

Authors:  Y-C Lin; Y-T Huang; T-F Lee; N-Y Lee; C-H Liao; S-Y Lin; W-C Ko; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2012-12-06       Impact factor: 4.434

View more
  2 in total

1.  Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Authors:  Luis Furuya-Kanamori; Thomas V Riley; David L Paterson; Niki F Foster; Charlotte A Huber; Stacey Hong; Tiffany Harris-Brown; Jenny Robson; Archie C A Clements
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients.

Authors:  Caroline Diorio; Paula D Robinson; Roland A Ammann; Elio Castagnola; Kelley Erickson; Adam Esbenshade; Brian T Fisher; Gabrielle M Haeusler; Susan Kuczynski; Thomas Lehrnbecher; Robert Phillips; Sandra Cabral; L Lee Dupuis; Lillian Sung
Journal:  J Clin Oncol       Date:  2018-09-14       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.